Ioanna Milenova and Marta Lopez-Gonzalez start secondments at TILT Biotherapeutics, Helsinki (Late Feb 2018)
Ioanna Milenova and Marta Lopez-Gonzalez have started their secondments at TILT Biotherapeutics in Helsinki. They will be performing in vivo studies using an established mouse melanoma model.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 643130.